• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血浆胆固醇酯转运蛋白的纯化与特性分析

Purification and characterization of a human plasma cholesteryl ester transfer protein.

作者信息

Hesler C B, Swenson T L, Tall A R

出版信息

J Biol Chem. 1987 Feb 15;262(5):2275-82.

PMID:3818596
Abstract

The cholesteryl ester transfer protein (CETP) binds to plasma lipoproteins and promotes transfer of cholesteryl esters between the lipoproteins. CETP has been purified 55,000-fold, with a 27% recovery of activity, from the d greater than 1.21 g/ml fraction of human plasma. In the final purification step, partially purified CETP is incubated with a synthetic lipid emulsion consisting of phosphatidylcholine, triglyceride, and fatty acid, and the bound activity, which elutes in the void volume, is separated from nonbound proteins by gel filtration on Sepharose 4B. Sodium dodecyl sulfate-gel analysis of fractions containing bound activity shows the presence of a single protein with an apparent Mr of 74,000. Inclusion of fatty acid in this emulsion was required to prevent the binding of a contaminant protein. However, incubation of CEPT with fatty acid emulsions containing lipid peroxides resulted in substantial inactivation and covalent degradation of the 74-kDa protein. This could be prevented by the inclusion of antioxidants during preparation of the emulsion. Solvent extraction of emulsion-bound CEPT gave a delipidated, active preparation. Purified IgG from a rabbit immunized with the 74-kDa protein completely removed activity from partially purified fractions. Amino acid analysis of the purified protein showed it to contain an unusually high content (45%) of nonpolar residues; the calculated hydrophobicity was greater than that of any other plasma apolipoprotein. These results show human CETP to be a unique plasma apolipoprotein with an apparent Mr of 74,000 which is hydrophobic, self-associating, and susceptible to covalent degradation by lipid peroxides.

摘要

胆固醇酯转运蛋白(CETP)与血浆脂蛋白结合,并促进脂蛋白之间胆固醇酯的转运。已从人血浆密度大于1.21 g/ml的组分中将CETP纯化了55000倍,活性回收率为27%。在最终纯化步骤中,将部分纯化的CETP与由磷脂酰胆碱、甘油三酯和脂肪酸组成的合成脂质乳剂一起孵育,然后通过Sepharose 4B凝胶过滤将在空体积中洗脱的结合活性与未结合的蛋白质分离。对含有结合活性的组分进行十二烷基硫酸钠凝胶分析,结果显示存在一种表观分子量为74000的单一蛋白质。该乳剂中必须包含脂肪酸以防止一种污染蛋白的结合。然而,将CETP与含有脂质过氧化物的脂肪酸乳剂一起孵育会导致74 kDa蛋白大量失活和共价降解。在乳剂制备过程中加入抗氧化剂可防止这种情况发生。对与乳剂结合的CETP进行溶剂萃取,得到了一种脱脂的活性制剂。用74 kDa蛋白免疫的兔子的纯化IgG可完全去除部分纯化组分中的活性。对纯化蛋白进行氨基酸分析,结果显示其非极性残基含量异常高(45%);计算出的疏水性大于任何其他血浆载脂蛋白。这些结果表明,人CETP是一种独特的血浆载脂蛋白,表观分子量为74000,具有疏水性、自我缔合性,且易被脂质过氧化物共价降解。

相似文献

1
Purification and characterization of a human plasma cholesteryl ester transfer protein.人血浆胆固醇酯转运蛋白的纯化与特性分析
J Biol Chem. 1987 Feb 15;262(5):2275-82.
2
Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.食源性脂血症期间高密度脂蛋白中胆固醇酯向含载脂蛋白B脂蛋白转移增强的机制
J Clin Invest. 1986 Apr;77(4):1163-72. doi: 10.1172/JCI112417.
3
Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity.胆固醇酯转移蛋白羧基末端缺失突变体对中性脂质的结合缺陷。羧基末端胆固醇酯结合位点对中性脂质转移活性至关重要的证据。
J Biol Chem. 1995 Jan 13;270(2):612-8. doi: 10.1074/jbc.270.2.612.
4
Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid.胆固醇酯转运蛋白促进高密度脂蛋白载脂蛋白A-I和A-II与低密度脂蛋白的结合:油酸的增强作用。
Biochim Biophys Acta. 1992 Aug 19;1127(3):255-62. doi: 10.1016/0005-2760(92)90229-o.
5
Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma.
J Biol Chem. 1988 Apr 15;263(11):5020-3.
6
Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.高密度脂蛋白颗粒的载脂蛋白组成对胆固醇酯转运蛋白活性的影响。含有不同比例载脂蛋白AI和AII的颗粒。
J Biol Chem. 1994 Feb 4;269(5):3189-97.
7
Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma.从人脂蛋白缺乏血浆中纯化和鉴定脂质转运蛋白
J Lipid Res. 1982 Sep;23(7):1058-67.
8
Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis.脂解增强胆固醇酯转运蛋白活性的机制。
J Biol Chem. 1985 Jun 10;260(11):6687-97.
9
Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.脂质转运抑制剂蛋白的分子克隆与表达揭示其与载脂蛋白F的同一性。
J Biol Chem. 1999 Jan 15;274(3):1814-20. doi: 10.1074/jbc.274.3.1814.
10
Modulation of the activity of the human cholesteryl ester transfer protein by carboxylated derivatives. Evidence for 13-cis-retinoic acid as a potent activator of the protein's activity in plasma.羧化衍生物对人胆固醇酯转运蛋白活性的调节。13-顺式视黄酸作为该蛋白在血浆中活性的有效激活剂的证据。
Eur J Biochem. 1996 Sep 15;240(3):699-706. doi: 10.1111/j.1432-1033.1996.0699h.x.

引用本文的文献

1
Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.胆固醇酯转运蛋白抑制剂与心血管结局:一项系统评价和荟萃分析
J Cardiovasc Dev Dis. 2024 May 16;11(5):152. doi: 10.3390/jcdd11050152.
2
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments.高胆固醇血症管理的药理学方法进展:新型治疗方法的全面概述
Biomedicines. 2024 Feb 14;12(2):432. doi: 10.3390/biomedicines12020432.
3
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
外周脂蛋白和胆固醇酯转移蛋白在血管性认知功能障碍和痴呆中的作用。
Mol Neurodegener. 2023 Nov 16;18(1):86. doi: 10.1186/s13024-023-00671-y.
4
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects.血栓病中异常血浆锌处理的治疗改善策略:针对脂肪酸/血清白蛋白介导的作用。
Int J Mol Sci. 2022 Sep 7;23(18):10302. doi: 10.3390/ijms231810302.
5
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.胆固醇酯转移蛋白抑制剂通过降低载脂蛋白 B 水平降低主要不良心血管事件。
Int J Mol Sci. 2022 Aug 20;23(16):9417. doi: 10.3390/ijms23169417.
6
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?胆固醇酯转移蛋白抑制剂:从高密度脂蛋白胆固醇到低密度脂蛋白胆固醇降低剂?
Cardiovasc Res. 2022 Nov 10;118(14):2919-2931. doi: 10.1093/cvr/cvab350.
7
Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.达塞曲匹和阿那曲匹对兔和猴体内高密度脂蛋白(HDL)的结构与功能有着不同影响。
J Lipid Res. 2017 Jul;58(7):1282-1291. doi: 10.1194/jlr.M068940. Epub 2017 May 17.
8
Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism.胆固醇酯转运蛋白脂质转运活性升高与静脉血栓栓塞风险相关。
J Atheroscler Thromb. 2016 Oct 1;23(10):1159-1167. doi: 10.5551/jat.32201. Epub 2016 May 9.
9
New Era of Lipid-Lowering Drugs.降脂药物的新时代。
Pharmacol Rev. 2016 Apr;68(2):458-75. doi: 10.1124/pr.115.012203.
10
Regulation of cholesteryl ester transfer protein expression by upstream polymorphisms: reduced expression associated with rs247616.上游多态性对胆固醇酯转运蛋白表达的调控:rs247616与表达降低相关。
Pharmacogenet Genomics. 2015 Aug;25(8):394-401. doi: 10.1097/FPC.0000000000000151.